Manufacturer
GlaxoSmithKline
Pharmaceutical manufacturer based in United Kingdom
United Kingdom
- Products listed
- 75
- Molecules
- 27
- Therapy areas
- 8
GlaxoSmithKline is a pharmaceutical manufacturer based in United Kingdom. MedsAcross lists 75 of its products across 27 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- United Kingdom
- Indian manufacturer
- No
- Also listed as
- GlaxoSmithKline LLC
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply GlaxoSmithKline products through licensed channels, with the documents your regulator needs.
Neurology
20 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Lamictal kit | Lamotrigine | US FDA | Available on request |
| Lamictal 100 mg tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal 150 mg tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal 2 mg tablet for oral suspensionOral | Lamotrigine | US FDA | Available on request |
| Lamictal 200 mg tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal 25 mg tablet for oral suspensionOral | Lamotrigine | US FDA | Available on request |
| Lamictal 25 mg tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal 5 mg tablet for oral suspensionOral | Lamotrigine | US FDA | Available on request |
| Lamictal ODT kit | Lamotrigine | US FDA | Available on request |
| Lamictal ODT 100 mg orally disintegrating tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal ODT 200 mg orally disintegrating tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal ODT 25 mg orally disintegrating tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal ODT 50 mg orally disintegrating tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal XR kit | Lamotrigine | US FDA | Available on request |
| Lamictal XR 100 mg extended-release tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal XR 200 mg extended-release tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal XR 25 mg extended-release tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal XR 250 mg extended-release tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal XR 300 mg extended-release tabletOral | Lamotrigine | US FDA | Available on request |
| Lamictal XR 50 mg extended-release tabletOral | Lamotrigine | US FDA | Available on request |
Respiratory
19 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Advair Diskus 100 mcg/50 mcg inhalation powderInhalation | Fluticasone propionate and Salmeterol | US FDA | Available on request |
| Advair Diskus 250 mcg/50 mcg inhalation powderInhalation | Fluticasone propionate and Salmeterol | US FDA | Available on request |
| Advair Diskus 500 mcg/50 mcg inhalation powderInhalation | Fluticasone propionate and Salmeterol | US FDA | Available on request |
| Advair HFA 115 mcg/21 mcg inhalerInhalation | Fluticasone propionate and Salmeterol | US FDA | Available on request |
| Advair HFA 230 mcg/21 mcg inhalerInhalation | Fluticasone propionate and Salmeterol | US FDA | Available on request |
| Advair HFA 45 mcg/21 mcg inhalerInhalation | Fluticasone propionate and Salmeterol | US FDA | Available on request |
| Anoro Ellipta 62.5 mcg/25 mcg inhalation powderInhalation | Umeclidinium and Vilanterol | US FDA | Available on request |
| Arnuity Ellipta 100 mcg inhalation powderInhalation | Fluticasone furoate | US FDA | Available on request |
| Arnuity Ellipta 200 mcg inhalation powderInhalation | Fluticasone furoate | US FDA | Available on request |
| Arnuity Ellipta 50 mcg inhalation powderInhalation | Fluticasone furoate | US FDA | Available on request |
| Breo Ellipta 100 mcg/25 mcg inhalation powderInhalation | Fluticasone furoate and Vilanterol | US FDA | Available on request |
| Breo Ellipta 200 mcg/25 mcg inhalation powderInhalation | Fluticasone furoate and Vilanterol | US FDA | Available on request |
| Breo Ellipta 50 mcg/25 mcg inhalation powderInhalation | Fluticasone furoate and Vilanterol | US FDA | Available on request |
| Exdensur 100 mg/1 mL injectionSubcutaneous Cold chain | Depemokimab | US FDA | Available on request |
| Incruse Ellipta 62.5 mcg inhalation powderOral | Umeclidinium | US FDA | Available on request |
| Serevent Diskus 50 mcg inhalation powderInhalation, oral | Salmeterol | US FDA | Available on request |
| Trelegy Ellipta 100 mcg/62.5 mcg/25 mcg inhalation powderInhalation | Fluticasone furoate, Umeclidinium and Vilanterol | US FDA | Available on request |
| Trelegy Ellipta 200 mcg/62.5 mcg/25 mcg inhalation powderInhalation | Fluticasone furoate, Umeclidinium and Vilanterol | US FDA | Available on request |
| Ventolin HFA 90 mcg inhalerInhalation | Albuterol | US FDA | Available on request |
Immunology and transplant
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Benlysta 120 mg/1.5 mL powder for injectionIntravenous Cold chain | Belimumab | US FDA | Available on request |
| Benlysta 200 mg/1 mL injectionSubcutaneous Cold chain | Belimumab | US FDA | Available on request |
| Nucala 100 mg/1 mL injectionSubcutaneous Cold chain | Mepolizumab | US FDA | Available on request |
| Nucala 100 mg/mL powder for injectionSubcutaneous Cold chain | Mepolizumab | US FDA | Available on request |
| Nucala 40 mg/0.4 mL injectionSubcutaneous Cold chain | Mepolizumab | US FDA | Available on request |
Oncology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Blenrep 50 mg/mL powder for injectionIntravenous Cold chain | Belantamab mafodotin | US FDA | Available on request |
| Jemperli 500 mg/10 mL injectionIntravenous Cold chain | Dostarlimab | US FDA | Available on request |
| Zejula 100 mg tabletOral | Niraparib | US FDA | Available on request |
| Zejula 200 mg tabletOral | Niraparib | US FDA | Available on request |
| Zejula 300 mg tabletOral | Niraparib | US FDA | Available on request |
Pain and anaesthesia
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Imitrex 100 mg tabletOral | Sumatriptan | US FDA | Available on request |
| Imitrex 25 mg tabletOral | Sumatriptan | US FDA | Available on request |
| Imitrex 4 mg/0.5 mL injectionSubcutaneous | Sumatriptan | US FDA | Available on request |
| Imitrex 50 mg tabletOral | Sumatriptan | US FDA | Available on request |
| Imitrex 6 mg/0.5 mL injectionSubcutaneous | Sumatriptan | US FDA | Available on request |
Haematology
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Jesduvroq 1 mg tabletOral | Daprodustat | US FDA | Available on request |
| Jesduvroq 2 mg tabletOral | Daprodustat | US FDA | Available on request |
| Jesduvroq 4 mg tabletOral | Daprodustat | US FDA | Available on request |
| Jesduvroq 6 mg tabletOral | Daprodustat | US FDA | Available on request |
| Jesduvroq 8 mg tabletOral | Daprodustat | US FDA | Available on request |
Psychiatry
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Wellbutrin SR 100 mg tabletOral | Bupropion | US FDA | Available on request |
| Wellbutrin SR 150 mg tabletOral | Bupropion | US FDA | Available on request |
| Wellbutrin SR 200 mg tabletOral | Bupropion | US FDA | Available on request |
Other products
10 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Blujepa 750 mg tabletOral | Gepotidacin | US FDA | Available on request |
| Hibsago 150 mg/1 mL injectionSubcutaneous Cold chain | Bepirovirsen | US FDA | Available on request |
| Krintafel 150 mg tabletOral | Tafenoquine | US FDA | Available on request |
| Malarone 250 mg/100 mg tabletOral | Atovaquone and Proguanil | US FDA | Available on request |
| Malarone 62.5 mg/25 mg tabletOral | Atovaquone and Proguanil | US FDA | Available on request |
| Mepron 750 mg/5 mL oral suspensionOral | Atovaquone | US FDA | Available on request |
| Ojjaara 100 mg tabletOral | Momelotinib | US FDA | Available on request |
| Ojjaara 150 mg tabletOral | Momelotinib | US FDA | Available on request |
| Ojjaara 200 mg tabletOral | Momelotinib | US FDA | Available on request |
| Utebzi 300 mg tabletOral | Tebipenem | US FDA | Available on request |
Molecules made
Fluticasone propionate and SalmeterolUmeclidinium and VilanterolFluticasone furoateBelimumabBelantamab mafodotinGepotidacinFluticasone furoate and VilanterolDepemokimabBepirovirsenSumatriptanUmeclidiniumDostarlimabDaprodustatTafenoquineLamotrigineAtovaquone and ProguanilAtovaquoneMepolizumabMomelotinibZanamivirSalmeterolFluticasone furoate, Umeclidinium and VilanterolTebipenemValacyclovirAlbuterolBupropionNiraparib
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from GlaxoSmithKline
Send a request for any of these products. We confirm the licensed source, documents and lead time.